Note 8 - Shareholders' Equity

6 Months Ended

Sep. 01, 2019

Notes to Financial Statements

Stockholders' Equity Note Disclosure [Text Block]

8

.

SHAREHOLDERS

’

EQUITY

During the

26

weeks ended

September 1, 2019,

the Company sold

29,174

shares of the Company’s treasury stock pursuant to the exercises of employee stock options, received proceeds of

$365

from such exercises and recognized stock-based compensation expense, net of recognized tax benefits, of

$265.

These transactions resulted in a

$235

increase in additional paid-in capital during the period.

On

January 8, 2015,

the Company announced that its Board of Directors authorized the Company’s purchase, on the open market and in privately negotiated transactions, of up to

1,250,000

shares of its common stock, representing approximately

6%

of the Company’s

20,945,634

total outstanding shares as of the close of business on

January 7, 2015.

This authorization superseded all prior Board of Directors’ authorizations to purchase shares of the Company’s common stock.

On

March 10, 2016,

the Company announced that its Board of Directors authorized the Company’s purchase, on the open market and in privately negotiated transactions, of up to

1,000,000

additional shares of its common stock, in addition to the unused prior authorization to purchase shares of the Company’s common stock announced on

January 8, 2015.

As a result, the Company is authorized to purchase up to a total of

1,531,412

shares of its common stock, representing approximately

7.5%

 of the Company’s 

20,517,939

total outstanding shares as of the close of business on

October 4, 2019.

The Company did

not

purchase any shares of its common stock during the

26

weeks ended

September 1, 2019

or during the

26

weeks ended

August 26, 2018.